Drug repurposing of dimethyl fumarate in Parkinson's disease: a promising disease-modifying strategy.

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of nigrostriatal dopaminergic neurons and pathological aggregation of a-synuclein. Despite advancements in symptomatic treatment, there is a critical unmet…

Preview only. Read the full abstract at the source